
BillionToOne, Inc. (NASDAQ: BLLN) Stock Competitors & Peer Comparison
See BLLN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BLLN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BLLN | $105.15 | -5.09% | 5B | 150.21 | $0.70 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.65% |
| TMO | $700.22 | +0.11% | 259.4B | 30.23 | $23.16 | +0.26% |
| DHR | $233.02 | +0.37% | 164B | 29.21 | $7.98 | +0.65% |
| IDXX | $704.23 | +0.89% | 55.5B | 49.52 | $14.22 | N/A |
| A | $173.96 | +0.55% | 49.1B | 29.94 | $5.81 | +0.59% |
| NTRA | $319.09 | -1.19% | 46.3B | -241.73 | -$1.32 | N/A |
| WAT | $460.25 | -0.42% | 45.2B | 33.64 | $13.68 | N/A |
| IQV | $265.12 | -2.21% | 43.7B | 21.84 | $12.13 | N/A |
| MTD | $1,738.91 | +0.46% | 34.6B | 39.97 | $43.51 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
BLLN vs DHR-PB Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, BLLN's ROE is +0.09%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
BLLN vs TMO Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, TMO has a market cap of 259.4B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while TMO trades at $700.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas TMO's P/E ratio is 30.23. In terms of profitability, BLLN's ROE is +0.09%, compared to TMO's ROE of +0.13%. Regarding short-term risk, BLLN is more volatile compared to TMO. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
BLLN vs DHR Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, DHR has a market cap of 164B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while DHR trades at $233.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas DHR's P/E ratio is 29.21. In terms of profitability, BLLN's ROE is +0.09%, compared to DHR's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to DHR. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DHR's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
BLLN vs IDXX Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, IDXX has a market cap of 55.5B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while IDXX trades at $704.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas IDXX's P/E ratio is 49.52. In terms of profitability, BLLN's ROE is +0.09%, compared to IDXX's ROE of +0.71%. Regarding short-term risk, BLLN is more volatile compared to IDXX. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check IDXX's competition here
Agilent Technologies, Inc. (NYSE: A)
BLLN vs A Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, A has a market cap of 49.1B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while A trades at $173.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas A's P/E ratio is 29.94. In terms of profitability, BLLN's ROE is +0.09%, compared to A's ROE of +0.20%. Regarding short-term risk, BLLN is more volatile compared to A. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check A's competition here
Natera, Inc. (NASDAQ: NTRA)
BLLN vs NTRA Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, NTRA has a market cap of 46.3B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while NTRA trades at $319.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas NTRA's P/E ratio is -241.73. In terms of profitability, BLLN's ROE is +0.09%, compared to NTRA's ROE of -0.09%. Regarding short-term risk, BLLN is more volatile compared to NTRA. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check NTRA's competition here
Waters Corporation (NYSE: WAT)
BLLN vs WAT Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, WAT has a market cap of 45.2B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while WAT trades at $460.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas WAT's P/E ratio is 33.64. In terms of profitability, BLLN's ROE is +0.09%, compared to WAT's ROE of +0.01%. Regarding short-term risk, BLLN is more volatile compared to WAT. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check WAT's competition here
IQVIA Holdings Inc. (NYSE: IQV)
BLLN vs IQV Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, IQV has a market cap of 43.7B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while IQV trades at $265.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas IQV's P/E ratio is 21.84. In terms of profitability, BLLN's ROE is +0.09%, compared to IQV's ROE of +0.22%. Regarding short-term risk, BLLN is more volatile compared to IQV. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check IQV's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
BLLN vs MTD Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, MTD has a market cap of 34.6B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while MTD trades at $1,738.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas MTD's P/E ratio is 39.97. In terms of profitability, BLLN's ROE is +0.09%, compared to MTD's ROE of +149.66%. Regarding short-term risk, BLLN is more volatile compared to MTD. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check MTD's competition here
Illumina, Inc. (NASDAQ: ILMN)
BLLN vs ILMN Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, ILMN has a market cap of 31.3B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while ILMN trades at $207.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas ILMN's P/E ratio is 41.16. In terms of profitability, BLLN's ROE is +0.09%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, BLLN is more volatile compared to ILMN. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ILMN's competition here
Labcorp Holdings Inc. (NYSE: LH)
BLLN vs LH Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, LH has a market cap of 30.1B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while LH trades at $370.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas LH's P/E ratio is 21.98. In terms of profitability, BLLN's ROE is +0.09%, compared to LH's ROE of +0.12%. Regarding short-term risk, BLLN is more volatile compared to LH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check LH's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
BLLN vs DGX Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, DGX has a market cap of 28.6B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while DGX trades at $259.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas DGX's P/E ratio is 25.62. In terms of profitability, BLLN's ROE is +0.09%, compared to DGX's ROE of +0.15%. Regarding short-term risk, BLLN is more volatile compared to DGX. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DGX's competition here
Guardant Health, Inc. (NASDAQ: GH)
BLLN vs GH Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, GH has a market cap of 20.5B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while GH trades at $151.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas GH's P/E ratio is -43.51. In terms of profitability, BLLN's ROE is +0.09%, compared to GH's ROE of +2.49%. Regarding short-term risk, BLLN is more volatile compared to GH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
BLLN vs EXAS Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas EXAS's P/E ratio is -95.37. In terms of profitability, BLLN's ROE is +0.09%, compared to EXAS's ROE of -0.04%. Regarding short-term risk, BLLN is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check EXAS's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
BLLN vs MEDP Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, MEDP has a market cap of 18.3B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while MEDP trades at $653.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas MEDP's P/E ratio is 36.25. In terms of profitability, BLLN's ROE is +0.09%, compared to MEDP's ROE of +1.00%. Regarding short-term risk, BLLN is more volatile compared to MEDP. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check MEDP's competition here
Revvity, Inc. (NYSE: RVTY)
BLLN vs RVTY Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, RVTY has a market cap of 17.2B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while RVTY trades at $154.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas RVTY's P/E ratio is 28.87. In terms of profitability, BLLN's ROE is +0.09%, compared to RVTY's ROE of +0.04%. Regarding short-term risk, BLLN is more volatile compared to RVTY. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check RVTY's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
BLLN vs ILMNV Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas ILMNV's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.09%, compared to ILMNV's ROE of N/A. Regarding short-term risk, BLLN is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ILMNV's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
BLLN vs CRL Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CRL has a market cap of 16.2B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CRL trades at $337.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CRL's P/E ratio is 34.14. In terms of profitability, BLLN's ROE is +0.09%, compared to CRL's ROE of +0.01%. Regarding short-term risk, BLLN is more volatile compared to CRL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CRL's competition here
ICON Public Limited Company (NASDAQ: ICLR)
BLLN vs ICLR Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, ICLR has a market cap of 14.6B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while ICLR trades at $194.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas ICLR's P/E ratio is 15.88. In terms of profitability, BLLN's ROE is +0.09%, compared to ICLR's ROE of +0.05%. Regarding short-term risk, BLLN is more volatile compared to ICLR. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ICLR's competition here
PerkinElmer, Inc. (NYSE: PKI)
BLLN vs PKI Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas PKI's P/E ratio is 41.45. In terms of profitability, BLLN's ROE is +0.09%, compared to PKI's ROE of +0.04%. Regarding short-term risk, BLLN is more volatile compared to PKI. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PKI's competition here
Qiagen N.V. (NYSE: QGEN)
BLLN vs QGEN Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, QGEN has a market cap of 10.3B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while QGEN trades at $49.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas QGEN's P/E ratio is 20.62. In terms of profitability, BLLN's ROE is +0.09%, compared to QGEN's ROE of +0.11%. Regarding short-term risk, BLLN is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check QGEN's competition here
RadNet, Inc. (NASDAQ: RDNT)
BLLN vs RDNT Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, RDNT has a market cap of 6B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while RDNT trades at $76.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas RDNT's P/E ratio is 166.13. In terms of profitability, BLLN's ROE is +0.09%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, BLLN is more volatile compared to RDNT. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check RDNT's competition here
GRAIL Inc. (NASDAQ: GRAL)
BLLN vs GRAL Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, GRAL has a market cap of 5.2B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while GRAL trades at $115.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas GRAL's P/E ratio is -11.89. In terms of profitability, BLLN's ROE is +0.09%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, BLLN is more volatile compared to GRAL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check GRAL's competition here
Sotera Health Company (NASDAQ: SHC)
BLLN vs SHC Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, SHC has a market cap of 4.7B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while SHC trades at $16.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas SHC's P/E ratio is 17.30. In terms of profitability, BLLN's ROE is +0.09%, compared to SHC's ROE of +0.26%. Regarding short-term risk, BLLN is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check SHC's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
BLLN vs SYNH Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas SYNH's P/E ratio is 61.40. In terms of profitability, BLLN's ROE is +0.09%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check SYNH's competition here
CareDx, Inc (NASDAQ: CDNA)
BLLN vs CDNA Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CDNA has a market cap of 4.1B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CDNA trades at $77.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CDNA's P/E ratio is 92.71. In terms of profitability, BLLN's ROE is +0.09%, compared to CDNA's ROE of +0.34%. Regarding short-term risk, BLLN is more volatile compared to CDNA. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CDNA's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
BLLN vs OLK Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas OLK's P/E ratio is -96.59. In terms of profitability, BLLN's ROE is +0.09%, compared to OLK's ROE of -0.07%. Regarding short-term risk, BLLN is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check OLK's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
BLLN vs NEO Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, NEO has a market cap of 2.1B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while NEO trades at $16.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas NEO's P/E ratio is 123.23. In terms of profitability, BLLN's ROE is +0.09%, compared to NEO's ROE of -0.04%. Regarding short-term risk, BLLN is more volatile compared to NEO. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check NEO's competition here
Veracyte, Inc. (NASDAQ: VCYT)
BLLN vs VCYT Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, VCYT has a market cap of 2B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while VCYT trades at $24.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas VCYT's P/E ratio is 12.17. In terms of profitability, BLLN's ROE is +0.09%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, BLLN is more volatile compared to VCYT. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check VCYT's competition here
Personalis, Inc. (NASDAQ: PSNL)
BLLN vs PSNL Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while PSNL trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas PSNL's P/E ratio is -14.41. In terms of profitability, BLLN's ROE is +0.09%, compared to PSNL's ROE of -0.50%. Regarding short-term risk, BLLN is more volatile compared to PSNL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PSNL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
BLLN vs WGS Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, WGS has a market cap of 1.6B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while WGS trades at $52.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas WGS's P/E ratio is 145.47. In terms of profitability, BLLN's ROE is +0.09%, compared to WGS's ROE of -0.42%. Regarding short-term risk, BLLN is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check WGS's competition here
OPKO Health, Inc. (NASDAQ: OPK)
BLLN vs OPK Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, OPK has a market cap of 1.2B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while OPK trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas OPK's P/E ratio is -18.67. In terms of profitability, BLLN's ROE is +0.09%, compared to OPK's ROE of -0.12%. Regarding short-term risk, BLLN is more volatile compared to OPK. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check OPK's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
BLLN vs CSTL Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CSTL has a market cap of 1B. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CSTL trades at $33.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CSTL's P/E ratio is -51.20. In terms of profitability, BLLN's ROE is +0.09%, compared to CSTL's ROE of -0.05%. Regarding short-term risk, BLLN is more volatile compared to CSTL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CSTL's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
BLLN vs FLGT Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, FLGT has a market cap of 689M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while FLGT trades at $24.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas FLGT's P/E ratio is 2466.00. In terms of profitability, BLLN's ROE is +0.09%, compared to FLGT's ROE of -0.09%. Regarding short-term risk, BLLN is more volatile compared to FLGT. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check FLGT's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
BLLN vs GRALV Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas GRALV's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.09%, compared to GRALV's ROE of N/A. Regarding short-term risk, BLLN is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check GRALV's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
BLLN vs MYGN Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, MYGN has a market cap of 542.9M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while MYGN trades at $5.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas MYGN's P/E ratio is -43.54. In terms of profitability, BLLN's ROE is +0.09%, compared to MYGN's ROE of -0.40%. Regarding short-term risk, BLLN is more volatile compared to MYGN. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check MYGN's competition here
Global Cord Blood Corporation (NYSE: CO)
BLLN vs CO Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CO's P/E ratio is 5.06. In terms of profitability, BLLN's ROE is +0.09%, compared to CO's ROE of +0.11%. Regarding short-term risk, BLLN is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check CO's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
BLLN vs FLDM Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas FLDM's P/E ratio is -4.74. In terms of profitability, BLLN's ROE is +0.09%, compared to FLDM's ROE of +0.26%. Regarding short-term risk, BLLN is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check FLDM's competition here
Genetron Holdings Limited (NASDAQ: GTH)
BLLN vs GTH Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas GTH's P/E ratio is -1.11. In terms of profitability, BLLN's ROE is +0.09%, compared to GTH's ROE of -1.01%. Regarding short-term risk, BLLN is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
BLLN vs GENE Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas GENE's P/E ratio is -38.25. In terms of profitability, BLLN's ROE is +0.09%, compared to GENE's ROE of -1.85%. Regarding short-term risk, BLLN is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check GENE's competition here
Exagen Inc. (NASDAQ: XGN)
BLLN vs XGN Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, XGN has a market cap of 105.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while XGN trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas XGN's P/E ratio is -5.10. In terms of profitability, BLLN's ROE is +0.09%, compared to XGN's ROE of -1.26%. Regarding short-term risk, BLLN is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check XGN's competition here
Freenome, Inc. (NASDAQ: FRNM)
BLLN vs FRNM Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, FRNM has a market cap of 84.9M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while FRNM trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas FRNM's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.09%, compared to FRNM's ROE of N/A. Regarding short-term risk, BLLN is less volatile compared to FRNM. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check FRNM's competition here
Biodesix, Inc. (NASDAQ: BDSX)
BLLN vs BDSX Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, BDSX has a market cap of 80.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while BDSX trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas BDSX's P/E ratio is -3.12. In terms of profitability, BLLN's ROE is +0.09%, compared to BDSX's ROE of -4.42%. Regarding short-term risk, BLLN is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BDSX's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
BLLN vs IMDX Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, IMDX has a market cap of 70M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while IMDX trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas IMDX's P/E ratio is -1.44. In terms of profitability, BLLN's ROE is +0.09%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, BLLN is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check IMDX's competition here
Precipio, Inc. (NASDAQ: PRPO)
BLLN vs PRPO Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, PRPO has a market cap of 39.6M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while PRPO trades at $22.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas PRPO's P/E ratio is -34.05. In terms of profitability, BLLN's ROE is +0.09%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, BLLN is more volatile compared to PRPO. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PRPO's competition here
Akumin Inc. (NASDAQ: AKU)
BLLN vs AKU Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas AKU's P/E ratio is -0.13. In terms of profitability, BLLN's ROE is +0.09%, compared to AKU's ROE of -5.32%. Regarding short-term risk, BLLN is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check AKU's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
BLLN vs CEMI Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CEMI's P/E ratio is -0.63. In terms of profitability, BLLN's ROE is +0.09%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, BLLN is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
BLLN vs ENZ Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas ENZ's P/E ratio is -2.24. In terms of profitability, BLLN's ROE is +0.09%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, BLLN is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
BLLN vs PMD Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas PMD's P/E ratio is -5.24. In terms of profitability, BLLN's ROE is +0.09%, compared to PMD's ROE of -0.32%. Regarding short-term risk, BLLN is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
BLLN vs ME Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas ME's P/E ratio is -0.03. In terms of profitability, BLLN's ROE is +0.09%, compared to ME's ROE of -3.47%. Regarding short-term risk, BLLN is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
BLLN vs MYNZ Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas MYNZ's P/E ratio is -1.33. In terms of profitability, BLLN's ROE is +0.09%, compared to MYNZ's ROE of -0.90%. Regarding short-term risk, BLLN is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MYNZ's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
BLLN vs QUCY Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, QUCY has a market cap of 14.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while QUCY trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas QUCY's P/E ratio is -0.03. In terms of profitability, BLLN's ROE is +0.09%, compared to QUCY's ROE of -2.44%. Regarding short-term risk, BLLN is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check QUCY's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
BLLN vs BNR Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, BNR has a market cap of 14M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while BNR trades at $13.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas BNR's P/E ratio is -15.23. In terms of profitability, BLLN's ROE is +0.09%, compared to BNR's ROE of -0.13%. Regarding short-term risk, BLLN is more volatile compared to BNR. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check BNR's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
BLLN vs BIAF Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, BIAF has a market cap of 13.8M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while BIAF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas BIAF's P/E ratio is -0.26. In terms of profitability, BLLN's ROE is +0.09%, compared to BIAF's ROE of -3.31%. Regarding short-term risk, BLLN is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BIAF's competition here
MDxHealth S.A. (NASDAQ: MDXH)
BLLN vs MDXH Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, MDXH has a market cap of 13.7M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while MDXH trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas MDXH's P/E ratio is -0.20. In terms of profitability, BLLN's ROE is +0.09%, compared to MDXH's ROE of +1.43%. Regarding short-term risk, BLLN is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MDXH's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
BLLN vs CHEK Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CHEK's P/E ratio is -0.43. In terms of profitability, BLLN's ROE is +0.09%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, BLLN is more volatile compared to CHEK. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
BLLN vs CNTG Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CNTG's P/E ratio is -0.23. In terms of profitability, BLLN's ROE is +0.09%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, BLLN is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CNTG's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
BLLN vs APDN Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas APDN's P/E ratio is -0.10. In terms of profitability, BLLN's ROE is +0.09%, compared to APDN's ROE of -5.84%. Regarding short-term risk, BLLN is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check APDN's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
BLLN vs NDRA Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, NDRA has a market cap of 6.6M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while NDRA trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas NDRA's P/E ratio is -0.66. In terms of profitability, BLLN's ROE is +0.09%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, BLLN is more volatile compared to NDRA. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check NDRA's competition here
Invitae Corporation (NYSE: NVTA)
BLLN vs NVTA Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas NVTA's P/E ratio is -0.00. In terms of profitability, BLLN's ROE is +0.09%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, BLLN is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NVTA's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
BLLN vs BIAFW Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, BIAFW has a market cap of 5.4M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while BIAFW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas BIAFW's P/E ratio is 0.57. In terms of profitability, BLLN's ROE is +0.09%, compared to BIAFW's ROE of -3.31%. Regarding short-term risk, BLLN is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BIAFW's competition here
LumiraDx Limited (NASDAQ: LMDX)
BLLN vs LMDX Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas LMDX's P/E ratio is -0.01. In terms of profitability, BLLN's ROE is +0.09%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, BLLN is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check LMDX's competition here
LumiraDx Limited (NASDAQ: LMDXW)
BLLN vs LMDXW Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, BLLN's ROE is +0.09%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, BLLN is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check LMDXW's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
BLLN vs ADVB Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, ADVB has a market cap of 4.2M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while ADVB trades at $2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas ADVB's P/E ratio is -23.00. In terms of profitability, BLLN's ROE is +0.09%, compared to ADVB's ROE of +0.58%. Regarding short-term risk, BLLN is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check ADVB's competition here
DermTech, Inc. (NASDAQ: DMTK)
BLLN vs DMTK Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas DMTK's P/E ratio is -0.04. In terms of profitability, BLLN's ROE is +0.09%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, BLLN is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check DMTK's competition here
Inotiv, Inc. (NASDAQ: NOTV)
BLLN vs NOTV Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas NOTV's P/E ratio is -0.03. In terms of profitability, BLLN's ROE is +0.09%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, BLLN is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NOTV's competition here
SeqLL Inc. (NASDAQ: SQL)
BLLN vs SQL Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas SQL's P/E ratio is -0.40. In terms of profitability, BLLN's ROE is +0.09%, compared to SQL's ROE of -30.46%. Regarding short-term risk, BLLN is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
BLLN vs AWH Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas AWH's P/E ratio is -0.09. In terms of profitability, BLLN's ROE is +0.09%, compared to AWH's ROE of +1.62%. Regarding short-term risk, BLLN is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check AWH's competition here
iSpecimen Inc. (NASDAQ: ISPC)
BLLN vs ISPC Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, ISPC has a market cap of 1.7M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while ISPC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas ISPC's P/E ratio is -0.02. In terms of profitability, BLLN's ROE is +0.09%, compared to ISPC's ROE of -5.24%. Regarding short-term risk, BLLN is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check ISPC's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
BLLN vs HTGM Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas HTGM's P/E ratio is -0.03. In terms of profitability, BLLN's ROE is +0.09%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, BLLN is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
BLLN vs BIOC Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas BIOC's P/E ratio is -0.01. In terms of profitability, BLLN's ROE is +0.09%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, BLLN is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BIOC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
BLLN vs SQLLW Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, BLLN's ROE is +0.09%, compared to SQLLW's ROE of +22.06%. Regarding short-term risk, BLLN is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check SQLLW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
BLLN vs WGSWW Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, BLLN's ROE is +0.09%, compared to WGSWW's ROE of -0.42%. Regarding short-term risk, BLLN is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check WGSWW's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
BLLN vs BNGOW Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas BNGOW's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.09%, compared to BNGOW's ROE of -0.85%. Regarding short-term risk, BLLN is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BNGOW's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
BLLN vs MEUSW Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas MEUSW's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.09%, compared to MEUSW's ROE of -3.47%. Regarding short-term risk, BLLN is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MEUSW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
BLLN vs PRXL Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas PRXL's P/E ratio is 42.97. In terms of profitability, BLLN's ROE is +0.09%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, BLLN is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PRXL's competition here
Danaher Corporation (NYSE: DHR-PA)
BLLN vs DHR-PA Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, BLLN's ROE is +0.09%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to DHR-PA. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DHR-PA's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
BLLN vs NDRAW Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas NDRAW's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.09%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, BLLN is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NDRAW's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
BLLN vs CHEKZ Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.09%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, BLLN is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check CHEKZ's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
BLLN vs OCDX Comparison November 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 5B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, BLLN is priced at $105.15 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 150.21, whereas OCDX's P/E ratio is -42.28. In terms of profitability, BLLN's ROE is +0.09%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, BLLN is more volatile compared to OCDX. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check OCDX's competition here